We are rebuilding biotech for the AI era.
When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific data and AI are built into how science gets done.
Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.
Chemaxon is a leading cheminformatics company, setting the industry standard for quality and accuracy. Over 1 million scientists, academics, and researchers use our tools to streamline their workflows and power their scientific breakthroughs.
Chemaxon joined Certara in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines.
Quartzy is a cloud-based platform that allows laboratories to streamline their communications, manage inventory, and purchase what they need to hit their milestones faster.
Watch the video: https://bit.ly/3kQzREz